BWX Technologies is rated a buy, supported by its exclusive role as the sole manufacturer of nuclear reactors and fuel for the U.S. Navy and strong government contracts that make up 67% of its revenue. The company also benefits from accelerating commercial nuclear opportunities, with a 45% growth forecast for fiscal year 2026. BWXT's strong $8.4 billion backlog, robust cash flow, and strategic acquisitions position it well to capitalize on rising demand for nuclear and AI-driven power. Key risks include exposure to fixed-price contracts, execution challenges, and sensitivity to U.S. government policy changes, but its unique market position provides a durable competitive advantage.
Alphabet CEO Sundar Pichai revealed that the company is facing challenges in rapidly expanding its AI capacity to meet demand. Meanwhile, competitor Anthropic has successfully secured 5 gigawatts of AI computing power, highlighting a significant deve...
Hyperscale Data, an AI data center company, sold about 65 Bitcoin worth $5.1 million to support the development of its Michigan data center. The company holds approximately 215 Bitcoin valued at $16.7 million as of August 30, 2026. The Michigan data ...
HEALWELL, via its subsidiary Orion Health, signed a multi-million-dollar, multi-year contract with Converge Health Iowa to implement its AI-powered SMART Search and SMART Summary tools across Iowa's statewide Health Information Exchange. These tools ...
Restart Life Sciences' premium brand Holy Crap Foods has launched in the U.S. through Amazon, featuring top super seed products and a variety pack. The company is expanding its U.S. presence with more SKUs and marketing efforts on Amazon to boost vis...
Amphastar Pharmaceuticals announced that CFO Bill Peters and EVP Tony Marrs will present at the Wells Fargo 21st Annual Healthcare Conference on September 8, 2026. The presentation will be webcast and available for 30 days on Amphastar's website. Amp...
